These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Phiel CJ; Wilson CA; Lee VM; Klein PS Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548 [TBL] [Abstract][Full Text] [Related]
12. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h. Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247 [TBL] [Abstract][Full Text] [Related]
13. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase. Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235 [TBL] [Abstract][Full Text] [Related]
14. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
15. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment. Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227 [TBL] [Abstract][Full Text] [Related]
16. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Zhou S; Zhou H; Walian PJ; Jap BK Proc Natl Acad Sci U S A; 2005 May; 102(21):7499-504. PubMed ID: 15890777 [TBL] [Abstract][Full Text] [Related]
17. A comparative assessment of gamma-secretase activity in transgenic and non-transgenic rodent brain. Goggi JL; Lewis HD; Mok J; Harrison T; Shearman MS; Atack JR; Best JD J Neurosci Methods; 2006 Oct; 157(2):246-52. PubMed ID: 16859750 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168 [TBL] [Abstract][Full Text] [Related]
19. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages. Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]